Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2, Cell & Bioscience

Robust Antiviral Activity of Santonica Flower Extract (Artemisia cina) against Avian and Human Influenza A Viruses: In Vitro and Chemoinformatic Studies

IJMS, Free Full-Text

Frontiers Natural Plant Products: A Less Focused Aspect for the COVID-19 Viral Outbreak

Traditional Medicinal Plants as the Potential Adjuvant, Prophylactic and Treatment Therapy for COVID-19 Disease: A Review

Frontiers Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective

Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective

Biologics, Free Full-Text

Saponin and Immune Stimulant Based Gargles and Nasal Rinses: A Potential Virucidal for Preventive Management of SARS-CoV-2 Infection?

SciELO - Brasil - Approach of utilizing Artemisia herbs to treat covid-19 Approach of utilizing Artemisia herbs to treat covid-19

Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 - Dogan - 2022 - Phytochemical Analysis